Search Results - Estrem ST
- Showing 1 - 1 results of 1
-
1
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway by Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book